Cohance Lifesciences board to meet on May 12, 2026 to approve audited financial results for Q4 and FY26.
The trading window for designated persons remains closed until May 14, 2026 as per earlier intimation.
Disclosure made pursuant to SEBI Listing Regulations Regulation 29 for mandatory board meeting intimation.